Skip to main content
Premium Trial:

Request an Annual Quote

Investment Bank Upgrades BD to Overweight, Raises Price Target

NEW YORK (GenomeWeb News) – Investment bank Piper Jaffray has upgraded its rating on Becton Dickinson's stock to Overweight and increased its price target.

Analyst William Quirk cited increased interest in microbiology diagnostic systems and BD's position in the market in a research note explaining the upgrade. In addition, he said BD could be poised to gain market share following a recent recall by Siemens of its MicroScan microbiology testing panels in the US.

BD sells the Kiestra lab automation system for clinical microbiology applications and the Phoenix automated microbiology system.

"As all manufacturers occasionally see recalls, we do not typically equate them with share shift, but given the significance of the Siemens' recall (class 1, 78,020 panels distributed over two years), we believe BD could see some incremental microbiology deals for its Phoenix system over the next year that could modestly benefit this segment's growth rate," Quirk wrote in the note.

"Combined with a delayed JNJ/Ypsomed pen needle launch and incremental European safety adoption, we believe numbers for BD will continue to climb and accordingly are raising our rating to Overweight with a $117 price target, up from $91," wrote Quirk.

Shares of BD closed up more than 1 percent at $102.32 in Wednesday trade on the New York Stock Exchange.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.